Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells

Diabetes

Volumn 52, Issue 4, 2003, Pages 929-934

  Gao, Yuan ^a   Walder, Ken ^a   Sunderland, Terry ^a   Kantham, Lakshmi ^a   Feng, Helen C ^a   Quick, Melissa ^a   Bishara, Natalie ^a   De Silva, Andrea ^a   Augert, Guy ^b   Tenne Brown, Janette ^a   Collier, Gregory R ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b Merck Sante   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLUCOSE; GLYCOGEN; INSULIN; INSULIN RECEPTOR; LIVER PROTEIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN TANIS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CONTROLLED STUDY; DIET RESTRICTION; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; HEPATOMA CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER METABOLISM; MICROSOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PSAMMOMYS OBESUS; RAT;

AMINO ACID SEQUENCE; ANIMALS; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS; DIABETES MELLITUS; GENE EXPRESSION; GERBILLINAE; GLUCOSE; GLYCOGEN; INSULIN; LIVER; MEMBRANE PROTEINS; MICROSOMES, LIVER; MITOCHONDRIA, LIVER; MOLECULAR SEQUENCE DATA; OBESITY; PEPTIDE FRAGMENTS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHORYLATION; RECEPTOR, INSULIN; TRANSFECTION; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 0037380429     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.4.929     Document Type: Article

References (39)

1. Seoane J, Barbera A, Telemaque-Potts S, Newgard CB, Guinovart JJ: Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J Biol Chem 274:31833-31838, 1999
2. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
3. Friedman JE, Yun JS, Patel YM, McGrane MM, Hanson RW: Glucocorticoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 268:12952-12957, 1993
4. Valera A, Pujol A, Pelegrin M, Bosch F: Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 91:9151-9154, 1994
5. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, Friedman JE: Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277:23301-23307, 2002
6. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB: Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620, 1998
7. Niswender KD, Shiota M, Postic C, Cherrington AD, Magnuson MA: Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272:22570-22575, 1997
8. O'Doherty RM, Lehman DL, Telemaque-Potts S, Newgard CB: Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48:2022-2027, 1999
9. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 47:509-531, 1996
10. Shafrir E, Gutman A: Psammomys obesus of the Jerusalem colony: a model for nutritionally induced, non-insulin-dependent diabetes. J Basic Clin Physiol Pharmacol 4:83-99, 1993
11. Barnett M, Collier GR, Collier FM, Zimmet P, O'Dea K: A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus. Diabetologia 37:671-676, 1994
12. Walder KR, Fahey RP, Morton GJ, Zimmet PZ, Collier GR: Characterization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Int J Exp Diabetes Res 1:177-184, 2000
13. Collier GR, McMillan JS, Windmill K, Walder K, Tenne-Brown J, de Silva A, Trevaskis J, Jones S, Morton GJ, Lee S, Augert G, Civitarese A, Zimmet PZ: Beacon: a novel gene involved in the regulation of energy balance. Diabetes 49:1766-1771, 2000
14. Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, De Silva A, Sunderland T, Godde N, Gao Y, Bishara N, Windmill K, Tenne-Brown J, Augert G, Zimmet PZ, Collier GR: Tanis: a link between type 2 diabetes and inflammation? Diabetes 51:1859-1866, 2002
15. Simpson LA, Yver DR, Hissin PJ, Wardzala LJ, Karnieli E, Salans LB, Cushman SW: Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions. Biochim Biophys Acta 763:393-407, 1983
16. Huang D, Cheung AT, Parsons JT, Bryer-Ash M: Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes. J Biol Chem 277:18151-18160, 2002
17. van Dijk TH, van der Sluijs FH, Wiegman CH, Baller JF, Gustafson LA, Burger HJ, Herling AW, Kuipers F, Meijer AJ, Reijngoud DJ: Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats: a pharmacological study with the chlorogenic acid derivative S4048. J Biol Chem 276:25727-25735, 2001
18. Bergmeyer HU: Methods of Enzymatic Analysis. New York, Academic Press, 1985
19. Grunfeld C, Dinarello CA, Feingold KR: Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells. Metabolism 40:894-898, 1991
20. Slosberg ED, Desai UJ, Fanelli B, St Denny I, Connelly S, Kaleko M, Boettcher BR, Caplan SL: Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein. Diabetes 50:1813-1820, 2001
21. Bai J, Cederbaum AI: Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against cytochrome P450 2E1-dependent toxicity in HepG2 cells. J Biol Chem 276:4315-4321, 2001
22. Hofmann C, Marsh JW, Miller B, Steiner DF: Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Diabetes 29:865-874, 1980
23. Valera A, Bosch F: Glucokinase expression in rat hepatoma cells induces glucose uptake and is rate limiting in glucose utilization. Eur J Biochem 222:533-539, 1994
24. Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK: Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 277:32234-32242, 2002
25. Magnuson MA, Quinn PG, Granner DK: Multihormonal regulation of phosphoenolpyruvate carboxykinase-chloramphenicol acetyltransferase fusion genes: insulin's effects oppose those of cAMP and dexamethasone. J Biol Chem 262:14917-14920, 1987
26. Ziv E, Kalman R, Hershkop K, Barash V, Shafrir E, Bar-On H: Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state. Diabetologia 39:1269-1275, 1996
27. Kalderon B, Gutman A, Levy E, Shafrir E, Adler JH: Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus). Diabetes 35:717-724, 1986
28. Marquie G, Duhault J, Jacotot B: Diabetes mellitus in sand rats (Psammomys obesus): metabolic pattern during development of the diabetic syndrome. Diabetes 33:438-443, 1984
29. Baulande S, Lasnier F, Lucas M, Pairault J: Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 276:33336-33344, 2001
30. Karpichev IV, Cornivelli L, Small GM: Multiple regulatory roles of a novel saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism. J Biol Chem 277:19609-19617, 2002
31. Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID: Skeletal muscle content of membrane glycoprotein PC-1 in obesity: relationship to muscle glucose transport. Diabetes 45:1324-1328, 1996
32. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V: Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes 47:1095-1100, 1998
33. Maddux BA, Goldfine ID: Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor α-subunit. Diabetes 49:13-19, 2000
34. Pender C, Ortmeyer HK, Hansen BC, Goldfine ID, Youngren JF: Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys. Metabolism 51:465-470, 2002
35. Goldfine ID, Maddux BA, Youngren JF, Frittitta L, Trischitta V, Dohm GL: Membrane glycoprotein PC-1 and insulin resistance. Mol Cell Biochem 182:177-184, 1998
36. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Yazaki Y, Kikuchi M, Oka Y, Asano T: No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes 48:1365-1371, 1999
37. Kumon Y, Suehiro T, Itahara T, Ikeda Y, Hashimoto K: Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus. Clin Biochem 27:469-473, 1994
38. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE: Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 276:42077-42083, 2001
39. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600, 2002